ONLY 51 cases (5.2%) of 984 adverse event following immunisation (AEFI) cases for COVID-19 vaccine booster shots were classified as serious as of Jan 20.
Health Ministry director-general Tan Sri Dr Noor Hisham Abdullah said the National Pharmaceutical Regulatory Agency (NPRA)’s AEFI Division received 24,111 AEFI reports, including 984 reports involving booster doses.
“Monitoring of AEFI reports received by the NPRA so far concluded that the trend and rate of AEFI reporting relating to booster doses did not show any increase from what was seen during the administration of the primer doses.
“The same reporting trend has been reported by other countries conducting COVID-19 booster dose immunisation programmes,” he said, in a statement.
He said fever, pain at the injection site, headaches, and fatigue were among the more common adverse effects reported by vaccine recipients.
Vaccine recipients who have adverse effects can make an AEFI report through the MySejahtera app for effects listed in the app.
They may also file an online report by filling in the Consumer Side Effect Reporting Form (ConSERF) at the NPRA website.
Meanwhile, Noor Hisham said new COVID-19 cases reported yesterday rose to 4,116 compared to 4,046 the day before, bringing total infections to 2,829,089 as of noon yesterday.
From that, 39 cases (0.9%) were Category 3, 4, and 5, while 4,077 cases (99.1%) were Category 1 and 2.
“A total of 498 cases were import cases while 3,618 were local cases. 141 cases required intensive care treatment while 62 cases needed respiratory support,” he added.
There were 2,858 recoveries yesterday, bringing the total to 2,753,119 recoveries overall. Also, nine new clusters were recorded, with 225 clusters still active. – Jan 23, 2022.
